No featured image available
Track athletes with high levels of testosterone will have to take suppressants if they want to compete in women’s sports, according to a Wednesday court ruling from the highest court in international sports.
The Swiss Court of Arbitration for Sport decided 2-1 that though restrictions on testosterone levels can be discriminatory, such discrimination is a “necessary, reasonable and proportionate means” of ensuring the fairness of female track and field competitions, The New York Times reported.
The case was brought to international attention after two-time Olympic champion Caster Semenya challenged testosterone limits for female athletes. The South African runner is widely believed to be intersex, a term defined by the United Nations as people born with sex characteristics “that do not fit typical binary notions of male or female bodies.”
Caster Semenya (#RSA) easily wins the Women’s 800m! #Rio2016 pic.twitter.com/EBwBLLzfo7
— #TokyoOlympics (@NBCOlympics) August 21, 2016
The court ruling was a victory for the International Association of Athletics Federations. The IAAF had said that competitors with “differences of sexual development,” specifically athletes born as men with male genital parts and increased levels of testosterone, have unfair advantages in regards to muscle mass, strength and oxygen-carrying capacity according to The NYT.
The court said there was a lack of evidence that athletes with increased levels of testosterone have unfair advantages in both the 1,500-meter race and the mile, according to the newspaper. This could allow Semenya, 28, to run 1,500-meter races without taking suppressants.
Follow Mary Margaret on Twitter.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].